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Summary
Introduction: Obesity and osteoporosis (OP) are two very prevalent diseases in our society today. The
effect of obesity on bone quality is currently a subject under discussion.
Objective: To assess the effect of body weight on the microstructure and biomechanical properties of tra-
becular bone biopsies from the proximal end of the femur in patients with hip fracture fragility.
Material and Methods: Cross-sectional study of 16 patients with hip fracture. The 2 groups are divided accor-
ding to their BMI: (A) normal weight individuals and (B) those with obesity. We collected biopsies of can-
cellous bone from the femoral head and assessed biochemical determinations (PTH, 25 (OH) vitamin D and
IGF-1), bone remodeling markers (PINP, CTX), bone mass (BMD neck and total hip), bone microstructure
and biomechanical study (µCt). Statistical analysis: Student's t test (SPSS 22.0) significance p<0.05.
Results: All patients had hip BMD in osteoporotic range. The obese group had higher levels of PTH and lower
IGF-1, vitamin D and PINP. We found no differences in the parameters related to bone metabolism. The
obese group showed better indices reaching microstructural significance: increased bone volume (BV/TV:
36.6±12.7 vs 19.4±11.4%, BS/TV: 5.5±1.1 vs 3.9±1.3%), higher trabecular number (Tb.N: 1.6±0.4 vs 1,01±0,4),
greater trabecular width (Tb.Th: 0.22±0.003 vs 0.17±0.05) and lower trabecular separation (Tb.Sp: 0.51±0.12
vs 0.66±0.16). Biomechanical parameters confirm greater strength of trabecular bone in obese patients.
Conclusion: Obesity may be a protective factor of bone quality in the femoral region and has less effect
on bone mineral density.
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Introduction
Obesity and osteoporosis (OP) are diseases that
have presented in epidemic form in recent deca-
des. Both are of multifactorial etiology and chro-
nic. They have a significant rate of morbimortality
in developed countries1,2. The relationship betwe-
en them has been studied extensively from diffe-
rent points of view, including epidemiological, cli-
nical and basic research, and different links have
been proposed, such as: 1) both are influenced by
genetic and environmental factors, or the interac-
tion between both; 2) aging is associated, with a
high incidence of bone loss and adiposity in the
bone marrow; 3) both bone remodeling and obe-
sity are regulated by a complex of adipocytokines
and hormones; 4) physical activity improves these
two diseases; and 5) adipocytes and osteoblasts
are derived from common progenitors3.
Obesity is determined by an imbalance in
which caloric intake exceeds consumption over a
prolonged period3,4 and constitutes a risk factor for
hypertension, dyslipidemia, diabetes mellitus, car-
diovascular disease and some forms of tumors5. 
Osteoporosis is a metabolic bone disease cha-
racterized by decreased bone strength due to a
reduction in bone quantity and/or quality, which
leads to an increased risk of spontaneous and
traumatic fractures6.
Traditionally, obesity has been considered a pro-
tective factor of bone loss and osteoporosis, becau-
se of the positive relationship between body weight,
or body mass index (BMI), with bone mineral den-
sity (BMD), which is one of the main determinants
of osteoporotic fracture risk7. This beneficial effect
of body weight on BMD has been mainly related to
increased bone formation due to mechanical loa-
ding, as well as the contribution of hormones deri-
ved from fatty tissue and its action on bone metabo-
lism6,8. It has been shown that the incidence of hip
fractures is decreased in subjects with a high BMI9.
Likewise, low BMI (below 18 kg/m2) reportedly pre-
sents a risk factor for osteoporotic fracture10. More
recent evidence, however, indicates that while over-
weight (BMI between 25-29 kg/m2) protects against
OP, obesity (BMI >30) interferes with bone health11.
Thus, fractures in children have been associated
with alterations in body composition, such as an
increase in adiposity and bone structure12 and a risk
of osteoporosis and non-vertebral fractures has
been reported in subjects with the highest propor-
tion of body fat, regardless of weight11. This has led
researchers to suggest that the relationship between
body mass index and obesity and the risk of frailty
fracture and BMD is complex. A meta-analysis
published in 2014 showed that more than 80% of
osteoporosis fractures (including the hip) were
found in women with a BMI <30 kg/m2 13 and in
obese women, a higher prevalence of fractures of
the proximal humerus and ankle14,15.
Changes in parameters related to bone metabo-
lism, such as insufficient levels of vitamin D and ele-
vated PTH, have also been reported in obesity,
along with markers of bone reshaping of formation
and resorption16, which points once again to a nega-
tive effect of fatty tissue on the bone. In addition,
energy metabolism is closely linked to the osteo-
blastic response to insulin regulating homeostasis
and bone remodeling. In stages of normaglycemia,
insulin stimulates osteoblastogenesis and the pro-
duction of RANKL inducing an increase in bone tur-
nover. On the other hand, the release to the envi-
ronment of decarboxylated osteocalcin regulates
insulin production in an endocrine manner17.
The effect of obesity on bone quality is
currently under debate and very few studies have
evaluated the microstructure and properties of
bone in this condition. Thus, an inverse relations-
hip between fat mass and the Trabecular Bone
Score (TBS), assessed in the lumbar spine, was
observed in premenopausal women with obesity,
whereas there was no relationship with the struc-
tural analysis of the hip (HSA)18. A reduction of
cortical bone has also been reported, due to a gre-
ater porosity, and yet an increase in volumetric
trabecular BMD analyzed by peripheral computed
tomography19 and a negative correlation of cortical
bone properties, resistance indexes (by micro-
indentation), with BMI and total fat mass20.
Our aim was to assess the effect of body
weight on the microstructure and biomechanical
properties of trabecular bone from femoral proxi-
mal extremity biopsies of obese patients versus
subjects with normal weight who present fragility
hip fracture.
Material and methods 
1. Study design and subjects included
The present research is an experimental, analytical
and transversal study of cases and controls. It was
approved by the Virgen Macarena University
Hospital Ethics Committee and informed, written
consent was obtained from all participants. All
included patients agreed to donate their bone
samples for the study.
Patients have been included randomly. They
entered our hospital’s Unit of Clinical Management
of Traumatology to be operated on for hip arthro-
plasty due to fracture or osteoporosis due to fragility
or fall in height below that of the individual without
acceleration mechanism, all were over 65 years of
age. We included 16 patients divided into two
groups according to BMI: 7 subjects formed group A
with BMI <25, and 9 had group B with BMI >30.
We excluded patients taking medication with
influence on bone metabolism (antiresorptive,
osteoformers, corticoids and anticonvulsants)
and/or vitamin D or calcium supplementation.
The clinical history, densitometric, istomorphome-
tric and biomechanical determinations were
carried out.
2. Clinical data
A medical history was carried out that included
data related to parentage; birthdate; anthropome-
tric measures: weight (kg); height (cm) and body
mass index (BMI) (weight in kg/height in m2).
History of osteoporosis and previous fractures
were also included.
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3. Biochemical determinations
Biochemical determinations, based on the serum
samples, performed at the Biochemistry Service of
the Virgen Macarena University Hospital (Seville).
Parameters included were: glucose, glycosyla-
ted hemoglobin (HbA1c), calcium, phosphorus,
insulin-like growth factor 1 (IGF-I), total alkaline
phosphatase (FAT), carboxyl terminal telopeptide
of type I collagen (β-CrossLaps) and amino-termi-
nal propeptide of collagen type I (P1NP) in auto-
antibody ADVIA 2400 (Siemens). Vitamin D [25
(OH) D3] and PTH were determined by chemilu-
minescent immunoassay (CLIA) on the CP ADVIA
Centaur Immunoassay (Siemens).
4. Assessment of bone mass
We measured bone mineral density (BMD) of the
lumbar spine (L2-L4) and hip (total hip and femoral
neck) by Dual Absorptiometry X-Ray (DXA, Hologic-
Discovery, Hologic Inc., Waltham, Massachusetts,
USA). The CV in vivo was 1.40% (L2-L4 column),
2.9% (femoral neck) and 2.5% (total hip).
5. Bone histomorphometry and biomechanical
study
Microstructural analysis of the biopsies was carried
out using computerized microtomography (micro-
CT), with SkyScan 1172, 100 kV, 1.3 MPixels. The
entire sample was scanned to reconstruct the images
and used for the quantitative and qualitative analysis
of the trabecular bone microstructure. To analyze this
microstructure, microtomography equipment softwa-
re (CTAn 1.7.0.5) was used. The quantitative variables
were: bone volume fraction (BV/TV), specific bone
surface (BS/BV), bone surface density (BS/TV), trabe-
cular thickness (Tb.Th), trabecular number),
Trabecular pattern factor (Tb.Sp), trabecular pattern
factor (Tb.Sp), trabecular pattern factor (Tb.Sp), ani-
sotropy degree (DA), and structure-index structures.
The samples were subjected to a mechanical
mono-axial compression test until rupture so as to
evaluate the elastic-plastic mechanical properties
of the biopsy (Microtest EM1/10/FR/m) at a cons-
tant loading speed and using a load cell of 1 kN
or 10 kN, once the force-displacement curve was
obtained Young's elastic modulus (E), the hard-
ness (u), the maximum supported voltage (σ), the
maximum force reached (F), the stiffness (S) and
the energy required to fracture (U).
6. Statistical Analysis
The variables were analyzed for normal distribu-
tion by the Kolmogorov-Smirnov test. Student's t-
test was performed to determine statistically signi-
ficant differences between the two groups.
The SPSS version 22.0 package for Windows
(IBM Corp., Armonk, New York, USA) was used
for the statistical management of results. In all
cases, the level significance was considered as p
<0.05. Data are expressed as mean ± SD.
Results
The anthropometric characteristics and BMD of
the hip, femoral neck and spine are shown in
Table 1. Both groups were similar in age, weight
and lifestyle. Absolutely expressed BMD values
and T-score of hip, femoral neck and spine were
lower in the normal weight group, obtaining the
greatest difference in hip T-score of -2.87±0,84 in
subjects with normal weight and -1.67±1.07 in
subjects with obesity although these differences
were not statistically significant.
The FRAX® 10-year risk of major fracture and
hip fracture was lower in obese patients than in
patients with a BMI <25 kg/m2, although it was not
statistically significant.
The biochemical analysis of parameters related
to bone metabolism is shown in Table 2. No diffe-
rences were observed between the two study
groups. It should be noted that vitamin D levels
were found below 20 ng/mL in almost all patients
studied independent of patients’ BMI.
Microstructural indices show differences in the
microarchitecture of spongy bone between both
groups (Figure 1). The group of obese subjects
presented higher BV/TV (p=0.015), BS/TV
(p=0.015), Tb.Th (p=0.04) and Tb.N (p=0.007). In
addition, they have less trabecular separation
Tb.Sp (p=0.038) and lower values  of Tb.Pf
(p=0.015) and SMI (p=0.012). Indicating all this a
better bone microstructure in the obese osteopo-
rotic subjects compared to those who presented
normal weight.
The biomechanical parameters studied (Figure
2) confirm a higher resistance of the trabecular
bone in obese patients compared to subjects with
normal weight. The obese group showed a grea-
ter rigidity, both in the stiffness due to the structu-
ral characteristics (p=0.029), and due to bone
material properties: Young's modulus (p=0.01),
maximum tension (p=0.036) and maximum force
reached (p=0.034). In addition, the energy requi-
red to fracture the obese osteoporotic bone is
twice that in subjects with normal weight,
although this difference did not reach statistical
significance.
Discussion  
The effect of obesity on bone tissue is still uncle-
ar. Although it is known that obese women have
reduced the volume of cortical bone and increa-
sed the volume of the trabecular bone19, there are
little data on the repercussion in the microstructu-
re and/or biomechanics of the bone of obese peo-
ple.
Our results indicate a positive effect of body
weight on parameters of microarchitecture and
biomechanics in trabecular bone. Although both
study groups have presented hip fracture, with
similar BMD values, bone quality characteristics
are better in the obese group than in normal
weight individuals.
The micro-CT study of the trabecular bone
biopsies of the femoral head from obese fractu-
red patients indicates that they present a greater
amount of bone, in relation to the total body
volume, greater bone density and greater number
of trabeculae, and that these are wider. At the
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same time, we also noted that the trabeculae
have less separation between them. All these
microstructural values correlate with the values
obtained in the biomechanical studies in which
we observe how the trabecular bone of the obese
patients present a greater rigidity and a greater
model of Young than the group of subjects with
a BMI <25 kg/m2.
We consider that this effect on the microarchi-
tecture may be due to two fundamental facts: hor-
monal and/or mechanical factors. At the hormonal
level, the increase in the aromatization of estro-
gens to androgens in adipose tissue leads to a
decrease in sex hormones bound to globulin, a
greater transformation of the adrenal hormones to
peripheral estrones and hyperinsulinemia, which
has a mitogenic effect on osteoblasts21. In addition,
these patients, when carrying greater weight, have
a greater mechanical activity on bone that may
also stimulate osteogenesis19,21-23.
The positive effect of body weight on bone tis-
sue also leads us to question whether fatty tissue,
muscle or both, to a greater or lesser extent, are
responsible for these results. If it is the greater
amount of fat or muscle tissue that is responsible
for this skeletal beneficial effect, we cannot be
sure, as we do not have data on hormone compo-
sition or serum levels of adipokines and myokines
for these subjects.
Our results do not agree with those of other
authors that indicate a worse bone microstructure
of the femur in obese subjects24. However, these
authors do not present results of bone biopsies
but the microstructural values  are evaluated by
DXA. Recently, Shen et al., in a similar study, have
not found such differences concluding that the
adipose tissue can interfere in the values  obtained
since by DXA, the soft tissues that surround the
bone, can give an erroneous reading in the mea-
surement of the area Bone and therefore the
amount of bone mineral content25,26.
Obesity is associated with increased bone mass
and a reduced risk of hip fractures. However,
other fractures such as those of the ankle or
humerus have a higher incidence in obese per-
sons27. In our case, BMD was comparable in both
study groups, the likelihood of fracture according
to FRAX® was also similar between subjects with
normal weight and obese, but we must consider
that in all our hip fracture patients, there was no
higher incidence of previous fractures in obese
people than those of normal weight.
Our obese patients have slight increases in
PTH levels and lower vitamin D and P1NP levels.
In healthy post-menopausal women, PTH values  
correlate positively with BMI19 and low levels of
vitamin D are described. These lower levels of
vitamin D have been attributed to a greater
absorption of this hormone by the adipocytes28
and to lower solar exposure, due to the more limi-
ted mobility of obese subjects29. On the other
hand, it has been reported that obese patients
tend to have less bone remodeling activity. It is
unknown whether this is due to the effect of other
diseases associated with obesity such as type 2
diabetes mellitus, among others, and/or by the
effect of adipokines and myokines on remode-
ling21,29.
Table 1. Anthropometric characteristics, FRAX® and BMD (mean ± standard deviation)
Normal weight Obese p
Gender (♂/♀) 3/4 2/7
Age (years) 78±9 79±7
Height (cm) 157±9 153±8
Weight (kg) 55.07±9.7 81.53±12.4
BMI (kg/m2) 22.1±2.4 33.8±3.6 0.000
10 year risk of major fracture (FRAX®) 16.5±9.8 13.8±12.0
10 year risk of hip fracture (FRAX®) 11.8±8.3 7.6±9.8
BMD femur neck (gHA/cm2) 0.456±0.16 0.52±0.09
BMD hip (gHA/cm2) 0.589±0.10 0.759±0.17
T-score neck -3.47±1.36 -3.02±0.64
T-score hip -2.87±0.84 -1.67±1.07
BMD column (gHA/cm2) 0.81±0.05 0.86±0.85
T-score column -2.57±0.67 -2.17±0.64
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Our study has several limitations: the main one is
the sample size, which is relatively small, but the
data obtained from microstructure and biomecha-
nics, which were the objectives of our study, are
quite forceful and statistically strong. We do not have
serum levels of adipokines and hormones derived
from the fatty tissue in order to relate them to the
microstructural and biomechanical parameters.
In conclusion, we can say that measurements
of trabecular bone biopsies from the femoral head
indicate that obese patients have better biomecha-
nical properties and better bone microarchitecture
than patients with normal weight, showing a
beneficial effect of body weight on bone quality.
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Figure 1. Comparison of structural parameters between patients with normal weight (A) and obese (B)
BV/TV: bone volume fraction; BS/BV: bone specific surface; BS/TV: bone surface density; Tb.Th: trabecular
thickness; Tb.N: trabecular number; Tb.Sp: trabecular separation; DA: degree of anisotropy; SMI: Structural
model index; Tb.Pf: trabecular connectivity.
Values  are expressed as mean ± SD. *statistically significant values.
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Figure 2. Comparison of biomechanical parameters between the two study groups: normal weight subjects (A)
and obese (B)
The parameters represented are: Young's elastic modulus (E); hardness (u); maximum supported voltage (σ);
maximum force reached (F); stiffness (S); energy needed to fracture (U).
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